Sino Biopharmaceutical Limited/ADR SBMFF
The SEC does not publish structured financial data (XBRL) for Sino Biopharmaceutical Limited/ADR, so there are no statement tables here.
This is common for foreign companies that trade over the counter and for filers that only submit documents.
Its filings are still listed below and on SEC EDGAR.
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| F-6 POS | Filing | Apr 6, 2026 | — |
| F-6EF | Form f-6ef | Jan 24, 2020 | — |
| F-6EF | Filing | Nov 22, 2019 | — |
| F-6 POS | Filing | Sep 29, 2017 | — |
| F-6EF | Filing | Sep 13, 2016 | — |
| F-6EF | Filing | May 25, 2016 | — |
| F-6EF | Filing | Apr 8, 2014 | — |
Company profile
- Listed as
- SBMFF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- New York, NY
- SEC CIK
- 1604982
Source: SEC EDGAR filings. This is company-reported data, not investment advice.